A Phase III, Double Blind, Randomized Study to Evaluate

Project: Research project

Project Details

Description

A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused byAspergillus Species or Other Filamentous Fungi
StatusFinished
Effective start/end date6/13/1112/31/14

Funding

  • Astellas Pharma US, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.